July 23, 2010 ·
Leave a comment
Press Release Out Today from the Offices of Thought Leader Select
July 22, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated key opinion leader research solutions to the biopharmaceutical industry, announces new key opinion leader research for an established Mexican pharmaceutical company.
The pharmaceutical company, a long-time presence in the Mexican market, has contracted the firm for key opinion leader identification, profiling, and engagement strategies in support of a novel prescription medication for the relief of muscle and joint pain. Thought Leader Select will assess the skills and experiences of a host of rheumatologists and orthopedic surgeons throughout Mexico. The pharmaceutical firm will engage the identified medical experts for one-on-one consultations, advisory boards, and speaking engagements, as well as potential clinical studies for new treatment indications for the drug.
In addition to profiles and activity plans for the leading Mexican physicians, Thought Leader Select will also deliver access to its exclusive web-based expert tool for optimizing physician teams for a variety of development activities.
“Our customized services, well-known throughout the United States and Canada, work for companies operating domestically in Mexico as well as multi-nationals doing business throughout Latin America,” stated Dr. Daniel Bagi, head of Latin American business development at Thought Leader Select, from his office in Mexico City. “The launch of this project establishes Thought Leader ... read more »
TAGS:
advisory boards
biopharmaceutical
biotechnology
Canada
clinical studies
Daniel Bagi
Europe
key opinion leader
KOL consulting
KOL engagement
KOL identification
KOL profiling
KOL strategies
Latin America
medical conferences
medical expert
Mexico
muscle and joint pain
North Carolina
orthopedic surgery
pain relief
pharmaceutical
prescription medication
Research Triangle
rheumatology
speakers bureaus
thought leader
Thought Leader Select
treatment indications
United States
June 15, 2010 ·
Leave a comment
New press release out today from the offices of Thought Leader Select–
FOR IMMEDIATE RELEASE
June 14, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to delivering sophisticated solutions for key opinion leader relationship management in the pharmaceutical industry, announces the launch of its KOL Incubator.
The company, known for its proprietary deep profiling research methodology that promotes industry engagement with the right medical experts in an array of therapeutic areas and disease states, has complemented its web-based tool for identifying medical expert teams for a variety of drug development needs. The KOL Incubator tracks new and young physicians as they engage in breakthrough clinical research, publish in medical journals, and speak at scientific conferences.
The new engine will track the progress of these health care providers, known in the healthcare community as “rising stars,” as they advance medical science. The incubator will gauge the impact of their work at regional, national, and international levels as their landmark work defines treatment guidelines for the next generation of medicines for better public health outcomes.
As these budding key opinion leaders accumulate a body of work that proves their standing of respect within the medical community, Thought Leader Select will move them into their core database of the world’s top medical experts. “This is an ideal role for us to play in advancing the ... read more »
TAGS:
advisory boards
clinical research
clinical trials
continuing medical education
deep-profiling
disease states
health care providers
healthcare
key opinion leaders
KOL engagement
KOL identification
KOL Incubator
KOL mapping
KOL profiling
Maher Noureddine
medical experts
medical journal publishing
research methodology
scientific conferences
speakers bureaus
therapeutic areas
Thought Leader Select
thought leaders